Company
Navigator Medicines
Charting a new course in inflammatory and autoimmune disease medicine.
- Business model
- B2B
- Legal name
- Navigator Medicines, Inc.
Claim, correct or request removal
Record updated 19 October 2026
About
Navigator Medicines is a clinical-stage biotech advancing bispecific antibodies, leading the advancement of biologics for targeted immune regulation & restoration.
Funding snapshot
- Total raised
- $50MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $10M2026-09-18
Funding rounds
- Round, 2026
- $10M2026-09-18, SEC form D sold
- Round, 2024
- $50M2024-08-23, SEC form D sold, 4 investors
Products
- Web
- NAV-240
- Web
- NAV-242
Loading relationship preview